Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
Sales | 4,042 | 12,003 | 4,729 | 3,399 | 2,629 |
Cost of Goods | 12,243 | 11,923 | 11,291 | 4,334 | 1,616 |
Gross Profit | -8,201 | 80 | -6,562 | -935 | 1,013 |
Operating Expenses | 8,575 | 11,546 | 8,157 | 7,801 | 7,566 |
Operating Income | -16,533 | -10,543 | -14,428 | -8,402 | -5,937 |
Interest Expense | 1,323 | 1,242 | 783 | 643 | 619 |
Other Income | 34 | -1,198 | 8 | 8 | 19 |
Pre-tax Income | -17,822 | -12,983 | -15,203 | -9,037 | -6,537 |
Net Income Continuous | -17,822 | -12,983 | -15,203 | -9,037 | -6,537 |
Net Income | $-17,822 | $-12,983 | $-15,203 | $-9,037 | $-6,537 |
EPS Basic Total Ops | -0.39 | -0.26 | -0.59 | -0.55 | -0.51 |
EPS Basic Continuous Ops | -0.39 | -0.26 | -0.59 | -0.55 | -0.51 |
EPS Diluted Total Ops | -0.39 | -0.26 | -0.59 | -0.55 | -0.51 |
EPS Diluted Continuous Ops | -0.39 | -0.26 | -0.59 | -0.55 | -0.51 |
EBITDA(a) | $-15,483 | $-8,892 | $-13,446 | $-7,976 | $-5,664 |